The Neuhauser syndrome was first described in 1975 . Three siblings in the same family and four other sporadic patients were found to have severe mental retardation, hypotonia, seizures, megalocornea (cornea diameter ≥13 mm) and hypoplasic irises, associated with minor dysmorphic findings, such as epicanthal folds, frontal bossing and depressed nasal bridge. Neuhauser suggested a possible recessive autosomal inheritance and called the condition MMR syndrome (megalocornea and mental retardation) 1 .
Since then, several other cases with similar signs and symptoms were reported in the literature, although some also had different and additional clinical findings 2-
10
. For example, Tominaga et al. 11 In 1991, Kimura et al. described a patient with the MMR syndrome associat-ed with hypothyroidism and myelination delay confirmed by cranial magnetic resonance studies 6 . Other findings described in the literature are bifid uvula, diffuse cortical atrophy, micrognathia, scoliosis, short stature, microcrania, hypertelorism, and hypotonia 2,4,6,7,10 .
The heterogeneity of this syndrome led Verloes to suggest 5 subtypes: 15 Subtype 1: a recessive form, as described by Neuhauser, with iris hypoplasia and minor anomalies; Subtype 2: a recessive form, as described by Franky-Temtay, with camptodactyly, scoliosis and growth retardation; Subtype 3: a recessive form, with normal irises, severe hypotonia, relative or absolute macrocephaly and other minor anomalies; Subtype 4: a possible Frydman type, with normal irises, macrocephaly and obesity; Subtype 5: provisionally unclassifiable cases.
The objective of this study is to describe a case of Neuhauser-type dysmorphism with refractory epileptic seizures.
Case
A 5-year-old boy born from non-consanguineous parents had a history of motor and speech development delay, severe mental retardation and marked psychomotor agitation. His motor skills problems were detected since he was eight months old. The clinical picture was compatible with spastic type of cerebral palsy. His electroencephalogram (EEG) showed marked independent bilateral and focal epileptiform discharges in both temporoparietal regions but predominantly in the right hemisphere. Cranial magnetic resonance imaging (MRI) showed prominent subarachnoid cortical sulci, Sylvian fissure, and basal cisterns (Figs 1 and 2) .
The patient was taking phenobarbital and had no history of seizures. When discontinuation of phenobarbital was gradually initiated, the patient developed seizures, initially of the tonic type. Carbamazepine was initiated, and seizure control was satisfactory.
Two months later, seizures started again with left sided tonic-clonic limb movements without changes in the level of consciousness. Seizures were controlled only af-ter diazepam and phenytoin were initiated, and patient had no seizures for 24 hours.
Clinical examination revealed severe mental retardation, psychomotor agitation, aggression and self-aggression, little visual contact with examiner, macrocephaly (above 95th percentile), megalocornea, thin and everted lower lip, decreased muscle bulk and tone, symmetrical and adequate muscle strength, and slightly wide-based gait. Preserved symmetrical myotatic reflexes, as well as abdominal and bilateral extensor plantar reflexes, were present. Patient did not react to sound stimuli; pupil diameters were equal, but pupils were poorly reactive to light; eye movements were normal.
Another EEG showed disorganization of base activity with rare sleep spindles, but no asymmetries. Severe multifocal epileptiform discharges were observed over the parietal region of the left hemisphere.
Generalized seizures affecting one side of the body started again; between these seizures, the patient had absence seizures and atonia of the left hemibody. Valproic acid was initiated and carbamazepine was gradually discontinued.
The intensity of seizures was reduced, but they still occurred daily. During gradual increase of valproic acid, the patient had vomits, inappetence, and altered state of consciousness (obnubilation, irritability and aggressiveness).
EEG was repeated and showed a decrease in epileptiform discharges, but was suggestive of diffuse toxic-metabolic encephalopathy. Valproic acid was suspected to be the cause of encephalopathy; therefore, it was discontinued and topiramate was initiated.
After this change in medication, the patient's state of consciousness progressed to normality. Seizure control was achieved with 10 mg/kg/day topiramate.
During hospitalization, several diagnostic exams were performed. Auditory evoked potential revealed bilateral neurosensorial hypoacusis. Ophthalmologic examination confirmed megalocornea; electroretinogram was normal, but visual evoked potential showed reduced visual acuity. Laboratory exams ruled out endocrine abnormalities. An informed consent was obtained with the parents for this publication.
DisCussion
The association of mental retardation and megalocornea, first described in 1975, characterizes a syndrome with marked phenotypic heterogeneity. About 36 cases have been reported in the literature, which suggests that it is a rare, non-progressive congenital anomaly associated with dysmorphic traits 1, 5, 9, 15 .
More recently, other new cases of Neuhauser syndrome have been described (Balci et al., Margari et al., Yarar et al.) 12-14 , but instead it continues to be a rare clinical situation. 
